Asolan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asolan

The following overview defines the identity and general purpose of Asolan (Alprazolam), adhering strictly to constraints against dosage, administration, side effects, and commercial claims.

Property Description
Active ingredient Alprazolam
Form Tablet (immediate/extended-release), Oral Solution
Pharmacological class Triazolobenzodiazepine, CNS Depressant
General use Relief of anxiety and tension
Origin Synthetic (chemically derived)

What Type of Medicine is Asolan? (Identity and Classification)

Asolan refers to a pharmaceutical preparation containing the synthetic compound Alprazolam, which is chemically recognized as a triazolobenzodiazepine, a specific, high-potency group within the broader benzodiazepine class. This chemical structure is key to the drug's activity, which is designated pharmacologically as a Central Nervous System (CNS) Depressant. This compound is classified as an anxiolytic and a psycholeptic due to its targeted action in reducing severe mental tension and apprehension. This specific formulation is fundamentally a single-ingredient product, focusing its activity entirely on Alprazolam.

Composition, Forms, and Origin of Alprazolam

The active compound in Asolan is Alprazolam, a substance that is entirely synthetic in origin, developed through deliberate chemical synthesis. This active component is prepared into various pharmaceutical preparations designed for oral administration, primarily including immediate-release tablets for rapid onset and extended-release tablets for sustained action over time, a differentiation recognized for the management of chronic tension. Alprazolam is also manufactured as a concentrated oral solution. The inactive components, or base/vehicle in tablets, consist of common pharmaceutical excipients necessary to ensure the proper formulation and disintegration of the solid dosage unit.

How Does Asolan Generally Help? (High-Level Purpose)

Asolan generally helps by selectively modulating and dampening excessive, overactive nerve signaling within the brain, thereby promoting a state of neural stabilization. The substance achieves this effect by interacting with the brain’s primary inhibitory system, which relies on the neurotransmitter gamma-aminobutyric acid (GABA). By enhancing the effectiveness of GABA, the medication produces a generalized calming and relaxing effect. This fundamental action of CNS depression is crucial, as it ultimately helps to relieve feelings of profound apprehension and acute unease, supporting its role as an anxiolytic in scenarios involving intense emotional distress.

What side effects are possible with Asolan?

Possible Side Effects and Safety Information

The safety profile for Asolan (Alprazolam) is defined by officially documented adverse reactions, classified by frequency and system involvement, as found in regulatory labeling.

Adverse Reaction Classification

Potential adverse effects are primarily related to the medicine’s central nervous system (CNS) depressant activity, which affects the nervous system and general body status.

Classification Common Examples (Regulatory Listing)
Very Common ( ge 10% ) Drowsiness, Sedation, Fatigue, Tiredness, Changes in appetite, Weight gain or loss.
Common ( 1% to <10% ) Impaired coordination (Ataxia), Dizziness, Memory impairment, Dysarthria, Depression, Insomnia, Constipation, Dry mouth.

Serious Adverse Reactions and Safety Constraints

Official labeling contains mandatory high-level warnings regarding several serious safety concerns. This includes the risk of Profound Sedation, Respiratory Depression, Coma, and Death when the medicine is used with Opioids or other CNS depressants, a restriction documented in regulatory Boxed Warnings. All benzodiazepines carry a serious warning concerning the risks of Abuse, Misuse, and Addiction.

Withdrawal is a critical safety consideration: Life-threatening Withdrawal Reactions, including seizures, are a risk upon abrupt discontinuation or rapid dose reduction, with the greatest seizure risk noted to be 24 to 72 hours post-reduction. The risk of dependence increases with longer treatment duration and higher daily dose.

Population-Specific Safety Notes

The safety profile includes special considerations for specific populations. Older Adults (Geriatric Patients) have an increased risk of adverse effects, including severe drowsiness, confusion, and unsteadiness, which may necessitate a lower starting dosage. Use during the later stages of Pregnancy can result in Neonatal Sedation and Withdrawal Syndrome (NOWS) in the newborn.

Overdose and Emergency Response

An overdose of Asolan (Alprazolam) is formally documented in regulatory prescribing information as an extension of its Central Nervous System (CNS) depressant activity. Documented clinical manifestations can range from somnolence and confusion to more severe signs such as impaired coordination, diminished reflexes, slurred speech, and loss of consciousness progressing to coma.

Life-threatening outcomes, including death, have been reported in association with Alprazolam overdose, particularly when combined with other CNS depressants. The risk of profound sedation, respiratory depression, and subsequent fatality is significantly increased with the concomitant ingestion of alcohol or opioid medications.

The official regulatory guidance mandates immediate action in a suspected overdose. Urgent medical attention is required if the individual is unresponsive, experiencing difficulty breathing, or has collapsed or had a seizure. Management procedures documented in labeling include maintaining an adequate airway, administering intravenous fluids, and employing general supportive measures such as immediate gastric lavage.

The use of the benzodiazepine antagonist Flumazenil may be considered; however, its application carries a documented risk of inducing seizure activity, particularly in patients who are long-term users of benzodiazepines. Following any intervention, monitoring of respiration, pulse rate, and blood pressure is required.

Therapeutic Uses of Asolan

What Asolan Treats: Main Uses and Benefits

Asolan (Alprazolam) is commonly used across domains where short-term symptomatic assistance is needed for managing pronounced and disruptive symptoms associated with anxiety and panic. The medication is indicated for the treatment of anxiety disorders and panic disorder. It provides supportive relief that generally helps to ease the overall symptom burden, aiming to support a sense of stability during periods of heightened tension or fear.


Key Therapeutic Contexts and Benefits

The medication is relevant in conditions characterized by periods of heightened symptoms, which include Generalized Anxiety Disorder (GAD) and recurrent Panic Disorder episodes. It is relevant for managing symptoms that interfere with daily comfort, such as pervasive worry, mental restlessness, palpitations, and heightened physiological activity.

Applied in scenarios where additional management of discomfort is required, Asolan generally supports a sense of stability during acute episodes. It may also assist with managing the intensity and recurrence of these unexpected manifestations.

This medicine is commonly used to help with symptoms related to heightened physiological activity that may occur concurrently with other conditions, such as clinical depression. Applicable within clinical settings that involve acute or unstable symptom patterns, it is relevant for managing the anxious component in these complex presentations, contributing to improved comfort during symptomatic phases.


Quick Fact: Support for Heightened Apprehension

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The official regulatory documents establish strict population eligibility rules for Asolan (Alprazolam). Use is primarily established for adults managing anxiety and panic disorders.

Contraindicated Populations

Asolan must not be used by individuals with a known hypersensitivity to alprazolam or any other benzodiazepine. Absolute prohibitions also apply to patients diagnosed with acute narrow-angle glaucoma, severe hepatic insufficiency (severe liver disease), severe respiratory insufficiency, myasthenia gravis, or severe sleep apnoea syndrome.

Age-Related and Conditional Restrictions

Use in the pediatric population (under 18 years) is not recommended because safety and efficacy have not been established by regulatory authorities. Older adults should use the medicine with caution due to increased sensitivity and reduced drug clearance. Caution is also advised for patients with impaired renal function or mild to moderate hepatic insufficiency. Furthermore, the medicine is restricted for use with the greatest caution in patients with a history of alcohol or drug abuse/dependence and in those with depression or suicidal tendencies.

Maternal Health

Use during pregnancy is generally not recommended due to the potential risk of fetal harm and neonatal withdrawal syndrome. The medicine is not recommended for use by lactating individuals as alprazolam is known to be excreted in human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Asolan (Alprazolam) is formally established based on its hepatic clearance and its pharmacological effect as a Central Nervous System (CNS) depressant.

Contraindicated and High-Risk Combinations

Co-administration with Ketoconazole and Itraconazole is officially contraindicated. These strong inhibitors of the CYP3A enzyme system significantly increase the plasma concentrations of Alprazolam (exposure) by impeding its metabolism.

Combining Alprazolam with opioid medicines is designated as high-risk, resulting in additive CNS depressant effects, which may lead to profound sedation and respiratory depression. This pharmacodynamic interaction also applies to co-administration with other sedating agents, such as other benzodiazepines and certain antipsychotics.

Metabolism and Exposure

  • CYP3A Inhibitors: Moderate inhibitors such as Nefazodone and Fluvoxamine officially increase Alprazolam exposure ( AUC) by reducing its clearance. For example, Fluvoxamine increases the AUC by approximately 1.96-fold.
  • CYP3A Inducers: Substances like Carbamazepine speed up metabolism, which may decrease Alprazolam plasma concentrations.
  • Other Drugs: Co-administration with Digoxin is noted to increase the risk of Digoxin toxicity by potentially raising its plasma levels.

Product and Lifestyle Interactions

  • Alcohol: Concomitant intake is formally not recommended due to the synergistic enhancement of CNS depression.
  • Cigarette Smoking: Smoking is documented to decrease Alprazolam concentrations by up to 50% due to increased clearance.

Mechanism of Action

How Asolan Works: Mechanism of Action

Amplifying the Brain’s Natural Inhibition

Asolan functions as a positive allosteric modulator that acts exclusively on Gamma-aminobutyric acid type A ( GABA A) receptors in the central nervous system (CNS). By binding to a site distinct from the GABA binding site, it enhances the affinity and effect of the naturally occurring inhibitory neurotransmitter GABA. This molecular interaction significantly increases the frequency of chloride ion channel opening.

The GABAergic System Cascade

The resulting influx of negatively charged chloride ions causes the postsynaptic neuron to become hyperpolarized, leading to a direct and widespread reduction in neuronal electrical excitability. This effect initiates a systemic GABAergic inhibitory cascade, dampening overactive neurological signaling across various brain pathways.

Modulation of Systemic Arousal

The functional consequence of this inhibitory cascade is systemic CNS depression, which produces core physiological adjustments including a reduction in central nervous system arousal, a decrease in motor reflex activity, and a slowing of cognitive processing, collectively shaping the drug’s physiological effect profile.

Dosage and Administration Information

How to Use Asolan

Asolan (Alprazolam) is administered strictly via the oral route and is available in forms including immediate-release (IR) tablets, extended-release (XR) tablets, and oral solutions. Official usage instructions define specific starting doses, frequency patterns, and rules for dose adjustment, based on established pharmaceutical guidelines.

Official Dosing and Administration

Usage Category Official Regulatory Instruction
Route of Administration Oral only.
Standard IR Starting Dose (Anxiety) 0.25 mg to 0.5 mg, three times daily.
Standard XR Starting Dose (Panic) 0.5 mg to 1 mg, once daily.
Dose Adjustment Interval No more frequently than every 3 to 4 days.
Maximum Daily Dose (Panic) Up to 10 mg per day.
Food Intake May be taken with or without food.

Procedural Conditions and Tapering

The method of administration depends on the formulation. Extended-release tablets must be swallowed whole and must not be crushed, chewed, or broken. For immediate-release forms, the doses should be distributed as evenly as possible throughout the waking hours.

Guidelines emphasize using the lowest effective dose for the shortest possible duration. Total treatment, including the mandatory dose reduction period, should generally not exceed 8 to 12 weeks. When discontinuing, the dose must be reduced gradually, typically by no more than 0.5 mg every 3 days to adhere to established tapering procedures.

Population-Specific Dosing

Adjusted starting doses are recommended for specific patient groups to ensure proper use:

  • Older Adults/Debilitated: The initial dose is reduced, starting at 0.25 mg administered two or three times daily (IR) or 0.5 mg once daily (XR).
  • Hepatic Impairment: The starting dose is also lowered to 0.25 mg two or three times daily (IR) or 0.5 mg once daily (XR).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Asolan (Alprazolam)

Evidence for Use in Generalized Anxiety Disorder (GAD)

Research examined the compound in studies focused on Generalized Anxiety Disorder (GAD), and in anxiety that sometimes occurs with depression. This exploration primarily involved controlled clinical studies known as randomized controlled trials (RCTs). These studies were used in research exploring how symptoms change over time, often comparing the compound against a placebo or other common therapies.

Researchers measured outcomes related to patient-reported discomfort and used standardized scales to evaluate changes in symptom patterns. Regulatory evaluations note that formal research support for continuous study outcomes does not extend beyond four months. What remains less clear is how outcomes are measured over the long term; limited information for long-term outcomes exists, and the results apply only to the populations studied in the short-term trials.

Evidence for Use in Panic Disorder

Research examined the compound in studies focused on conditions characterized by acute or disruptive episodes of panic. The evidence base includes a number of large, short-term randomized clinical trials that focused on outcomes describing episodic or acute changes in symptoms. Researchers monitored changes in the frequency and intensity of panic attacks over set periods, typically exploring short-term symptom changes over intervals ranging from 4 to 10 weeks.

Studies reported measurements of changes when comparing the compound to placebo within these time-limited research contexts. Comparative evidence against other medications in the same class (benzodiazepines) described study findings where no significant differences in measured outcomes were reported across pooled trial results.

Key Limitations and Remaining Scientific Questions

Scientific and regulatory analyses indicate that the research landscape has specific limitations. One noted concern is publication bias in research related to the extended-release formulation for Panic Disorder. Additionally, the research highlights changes measured during the study period, but the long-term effects are not fully established due to the limited follow-up durations in the majority of key trials.

Key Studies & References

  1. Unpublished trials of alprazolam XR and their influence on its apparent efficacy for panic disorder (Analysis of publication bias for extended-release formulation)
  2. Generalised anxiety disorder and panic disorder in adults: management (Clinical guideline covering pharmacological treatment and benzodiazepine role)

Frequently Asked Questions (FAQ)

Common questions about Asolan (FAQ)

Q: Is Asolan used for conditions other than the primary one listed?

A: Official regulatory documents state that Asolan (alprazolam) is formally indicated for the management of anxiety disorders and the treatment of panic disorder. The uses supported by the evidence and approved by regulators are specifically defined within these two broad areas.


Q: Does Asolan work immediately after taking it?

A: According to the official product information, after the medicine is taken by mouth, it is readily absorbed into the body. Peak concentrations in the blood are typically reached within about one to two hours.


Q: How long does the effect of a dose of Asolan typically last?

A: Official pharmacokinetic studies help explain how long the medicine remains active. The mean elimination half-life—the time it takes for half the drug to be eliminated from the body—is reported to be around 11.2 hours in healthy adults, though this can vary widely.


Q: Are there any common over-the-counter medicines that interact with Asolan?

A: Official drug labels list various medications that can increase side effects due to additive central nervous system (CNS) depression, which is a calming and slowing effect. These medicines include certain over-the-counter antihistamines.


Q: Can vitamins or herbal supplements cause problems when taken with Asolan?

A: Official regulatory guidance emphasizes the importance of sharing information with a health provider about all medications, including vitamins and herbal supplements. This caution is advised because certain supplements may interact with or change the body's processing of the medication.


Q: What kind of foods or drinks should be avoided while taking Asolan?

A: The use of alcohol is formally not recommended because it can synergistically enhance the drug's CNS depressant effects. Some official documents also note that certain non-alcoholic beverages, such as grapefruit juice, may impact how the body processes the medication.


Q: Is it normal to have mild stomach upset when first using Asolan?

A: Common gastrointestinal side effects listed in regulatory documents include constipation and dry mouth. While other less common digestive effects are sometimes reported, they are not typically classified as the most frequent side effects.


Q: Does Asolan affect blood pressure or heart rate?

A: Official safety information indicates that Asolan, due to its action as a CNS depressant, may cause systemic hypotension, which is low blood pressure. This effect is especially noted when the medicine is used in combination with other central depressants.


Q: Does Asolan interact with birth control pills?

A: The medicine is primarily processed by the CYP3A4 enzyme system in the body. If a birth control pill contains components that strongly inhibit or induce (speed up or slow down) the CYP3A4 system, an interaction that changes the medicine's concentration may occur.


Q: How long does Asolan stay in your system after the last dose?

A: Official pharmacokinetic data indicates the drug has a mean elimination half-life of approximately 11.2 hours in healthy adults. This half-life is used to estimate the time required for the drug to be largely cleared from the body, though the rate varies between individuals.


Q: Why do official documents mention specific populations being excluded from using Asolan?

A: Specific exclusions and use restrictions are put in place based on safety risks documented by regulators. For instance, the drug is contraindicated in severe liver disease because the body's rate of drug elimination is reduced, which could lead to drug accumulation and potential toxicity.


Q: Does Asolan require special monitoring, like blood tests, during treatment?

A: Regulatory guidelines specify that usual precautions should be observed when treating patients with impaired renal (kidney), hepatic (liver), or pulmonary (lung) function. Additionally, monitoring may be relevant when hepatic function is impaired.


Q: What is the difference between how Asolan works and how similar drugs work?

A: Official descriptions classify Asolan (alprazolam) as a triazolo analog within the broader benzodiazepine class. Its general function is to enhance the effect of the inhibitory neurotransmitter GABA, leading to a general reduction in nerve activity.


Q: What should I do if I forget to take a dose of Asolan?

A: The official patient information describes guidance for missed doses, which generally involves taking the dose only if sufficient time remains before the next scheduled dose, while emphasizing that a patient should not double the dose.


Q: How does the time of day I take Asolan affect its performance?

A: Regulatory guidance for the immediate-release form of the medication indicates that the times of administration are distributed as evenly as possible throughout the waking hours. This procedure is described as helping to maintain a consistent amount of the medication in the body throughout the day.


Q: Is Asolan a prescription-only medicine?

A: Yes, Asolan (alprazolam) is classified by regulatory bodies as a Schedule IV controlled substance. This official classification means that the medicine is only legally available through a valid prescription from a licensed healthcare provider.


Q: What is the significance of the research evidence themes mentioned in official sources?

A: Clinical studies included in regulatory documents are used to establish the drug's safety and effectiveness. The evidence supports the drug's use for only the formally indicated conditions and for the time periods that were studied, such as short-term use for panic disorder.


Q: Can I take Asolan if I have a history of allergic reactions to other medications?

A: Official documents state that the drug is strictly contraindicated (must not be used) in patients with a known sensitivity to alprazolam or other benzodiazepines. The official safety information notes that individuals with a history of allergic reactions to any medication should ensure this complete history is reviewed by a healthcare professional.


Q: Why does the packaging of Asolan list specific inactive ingredients?

A: Inactive ingredients are required to be listed on packaging to comply with regulatory mandates. This informs patients of all the components of the medicine, which may include materials such as lactose or specific dyes.


Q: How does Asolan affect vision?

A: Official regulatory documents list double vision (diplopia) as a serious adverse reaction. Safety information directs that any such visual disturbances are to be reported to a healthcare provider.


Q: Why is eligibility for Asolan often strictly defined in medical guidelines?

A: Eligibility is strictly defined because of the serious safety constraints outlined in regulatory documents. These include mandatory warnings about the risks of profound sedation when combined with opioids, and the established risk of abuse, misuse, and addiction.


Q: Can Asolan be taken alongside pain relievers like ibuprofen?

A: Regulatory documents list a wide range of potential drug interactions based on the medicine's metabolic pathway. While common pain relievers like ibuprofen are not specifically named as a major interaction, regulatory information notes that the comprehensive interaction profile of the medication requires that all co-administered medications be reviewed by a healthcare provider.


Q: How soon after stopping Asolan can I start taking 'Z' medication?

A: Official guidance requires a mandatory tapering process, which involves a gradual dose reduction over several weeks to safely discontinue use. Given that the drug's elimination half-life is around 11.2 hours, the complete clearance time will vary based on the duration of the taper.


Q: Is "Asolan" a generic or brand name for Alprazolam?

A: The active therapeutic ingredient is alprazolam, which is the generic name of the compound. Asolan is a simulated name used in this context, but well-known registered brand names for the drug in the United States include Xanax and Niravam.

How should Asolan be stored and disposed of?

Storage Requirements

Asolan must be stored at Controlled Room Temperature between 20 C to 25 C (68 F to 77 F), with permitted short excursions up to 30 C. The medicine must be kept in its original container and the container must remain tightly closed.

It is required to protect the product from excessive heat, moisture, and light; therefore, it should not be stored in a bathroom. The oral solution form must be protected from freezing. If the solution freezes, it should be warmed to room temperature before use.

Handling and Disposal

For household safety, this medicine must always be stored out of the sight and reach of children.

Unused or expired Asolan should be disposed of via a drug take-back program (pharmacy or collection site). If a take-back program is unavailable, the product should be mixed with an undesirable substance (such as used coffee grounds) in a sealed container and placed in the household trash. It should not be flushed down a toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Asolan found in:

A-Z Index: